{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:58:35Z","timestamp":1788483515230,"version":"build-2803163510"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>This study aims to provide an overview of outcomes after right ventricular outflow tract (RVOT) reconstruction using different valve substitutes in different age groups for different indications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The literature was systematically searched for articles published between January 2000 and June 2021 reporting on clinical and\/or echocardiographic outcomes after RVOT reconstruction with valve substitutes. A random-effects meta-analysis was conducted for outcomes, and time-related outcomes were visualized by pooled Kaplan\u2013Meier curves. Subgroup analyses were performed according to etiology, implanted valve substitute and patient age.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Two hundred and seventeen articles were included, comprising 37,078 patients (age: 22.86 \u00b1 11.29 years; 31.6% female) and 240,581 patient-years of follow-up. Aortic valve disease (Ross procedure, 46.6%) and Tetralogy of Fallot (TOF, 27.0%) were the two main underlying etiologies. Homograft and xenograft accounted for 83.7 and 32.6% of the overall valve substitutes, respectively. The early mortality, late mortality, reintervention and endocarditis rates were 3.36% (2.91\u20133.88), 0.72%\/y (95% CI: 0.62\u20130.82), 2.62%\/y (95% CI: 2.28\u20133.00), and 0.38%\/y (95%CI: 0.31\u20130.47) for all patients. The early mortality for TOF and truncus arteriosus (TA) were 1.95% (1.31\u20132.90) and 10.67% (7.79\u201314.61). Pooled late mortality and reintervention rate were 0.59%\/y (0.39\u20130.89), 1.41%\/y (0.87\u20132.27), and 1.20%\/y (0.74\u20131.94), 10.15%\/y (7.42\u201313.90) for TOF and TA, respectively. Endocarditis rate was 0.21%\/y (95% CI: 0.16\u20130.27) for a homograft substitute and 0.80%\/y (95%CI: 0.60\u20131.09) for a xenograft substitute. Reintervention rate for infants, children and adults was 8.80%\/y (95% CI: 6.49\u201311.95), 4.75%\/y (95% CI: 3.67\u20136.14), and 0.72%\/y (95% CI: 0.36\u20131.42), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study shows RVOT reconstruction with valve substitutes can be performed with acceptable mortality and morbidity rates for most patients. Reinterventions after RVOT reconstruction with valve substitutes are inevitable for most patients in their life-time, emphasizing the necessity of life-long follow-up and multidisciplinary care. Follow-up protocols should be tailored to individual patients because patients with different etiologies, ages, and implanted valve substitutes have different rates of mortality and morbidity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p>[<jats:ext-link>www.crd.york.ac.uk\/prospero<\/jats:ext-link>], identifier [CRD42021271622].<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.897946","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T05:03:09Z","timestamp":1662526989000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Outcomes after right ventricular outflow tract reconstruction with valve substitutes: A systematic review and meta-analysis"],"prefix":"10.3389","volume":"9","author":[{"given":"Xu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Bakhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad J. J. C.","family":"Bogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R. G.","family":"Etnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlijn C. E. M.","family":"van Der Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolien W.","family":"Roos-Hesselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni-Rosalina","family":"Andrinopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna J. M.","family":"Takkenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.jtcvs.2016.07.031","article-title":"Pulmonary valve replacement for congenital heart disease: What valve substitute should we be using?","volume":"152","author":"Mitchell","year":"2016","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.athoracsur.2020.06.036","article-title":"Surgery for truncus arteriosus: Contemporary practice.","volume":"111","author":"Naimo","year":"2020","journal-title":"Ann Thorac Surg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/ejcts\/ezaa030","article-title":"Long-term outcomes of pulmonary valve replacement in patients with repaired tetralogy of Fallot.","volume":"58","author":"Lee","year":"2020","journal-title":"Eur J Cardiothorac Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(67)90794-5","article-title":"Replacement of aortic and mitral valves with a pulmonary autograft.","volume":"2","author":"Ross","year":"1967","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.athoracsur.2010.06.078","article-title":"Homografts and xenografts for right ventricular outflow tract reconstruction: Long-term results.","volume":"90","author":"Christenson","year":"2010","journal-title":"Ann Thorac Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/S1010-7940(00)00414-0","article-title":"Reconstruction of the RVOT with valved biological conduits: 25 Years experience with allografts and xenografts.","volume":"17","author":"Homann","year":"2000","journal-title":"Eur J Cardio Thoracic Surg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1017\/S1047951119000143","article-title":"Contegra versus pulmonary homograft for right ventricular outflow tract reconstruction in newborns.","volume":"29","author":"Falchetti","year":"2019","journal-title":"Cardiol Young."},{"key":"B8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1055\/s-0029-1185513","article-title":"European Contegra multicentre study: 7-year results after 165 valved bovine jugular vein graft implantations.","volume":"57","author":"Breymann","year":"2009","journal-title":"Thorac Cardiovasc Surg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.athoracsur.2005.02.053","article-title":"Right ventricular outflow tract reconstruction with an allograft conduit in non-ross patients: Risk factors for allograft dysfunction and failure.","volume":"80","author":"Brown","year":"2005","journal-title":"Ann Thorac Surg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ejcts\/ezu080","article-title":"Which type of conduit to choose for right ventricular outflow tract reconstruction in patients below 1 year of age?","volume":"46","author":"Vitanova","year":"2014","journal-title":"Eur J Cardio Thorac Surg."},{"key":"B11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ejcts.2010.01.063","article-title":"Comparison of bovine jugular vein with pulmonary homograft conduits in children less than 2 years of age.","volume":"38","author":"Fiore","year":"2010","journal-title":"Eur J Cardio Thorac Surg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/ejcts\/ezaa244","article-title":"Allografts and xenografts for right ventricular outflow tract reconstruction in Ross patients.","volume":"59","author":"Sharifulin","year":"2020","journal-title":"Eur J Cardiothorac Surg."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.athoracsur.2007.12.082","article-title":"Guidelines for reporting mortality and morbidity after cardiac valve interventions.","volume":"85","author":"Akins","year":"2008","journal-title":"Ann Thorac Surg."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range.","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range.","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jclinepi.2006.11.003","article-title":"Effect sizes can be calculated for studies reporting ranges for outcome variables in systematic reviews.","volume":"60","author":"Walter","year":"2007","journal-title":"J Clin Epidemiol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: Reconstructing the data from published Kaplan-Meier survival curves.","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis.","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jtcvs.2017.04.072","article-title":"Mechanical valves in the pulmonary position: An international retrospective analysis.","volume":"154","author":"Pragt","year":"2017","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0003-4975(00)02440-1","article-title":"Right ventricular outflow tract reconstruction with an allograft conduit.","volume":"71","author":"Gerestein","year":"2001","journal-title":"Ann Thorac Surg."},{"key":"B22","first-page":"478","article-title":"Does the homograft for RVOT reconstruction in ross: Patients fare better than for non-ross patients? A single-center experience.","volume":"24","author":"Ruzmetov","year":"2015","journal-title":"J Heart Valve Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jtcvs.2005.04.003","article-title":"Pulmonary position cryopreserved homografts: Durability in pediatric Ross and non-Ross patients.","volume":"130","author":"Selamet Tierney","year":"2005","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0003-4975(00)01788-4","article-title":"Cryopreserved homografts in the pulmonary position: Determinants of durability.","volume":"71","author":"Forbess","year":"2001","journal-title":"Ann Thorac Surg."},{"key":"B25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/14017430410016387","article-title":"Factors influencing late allograft valve failure.","volume":"38","author":"Yap","year":"2004","journal-title":"Scand Cardiovasc J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.cjca.2017.06.011","article-title":"Pulmonary valve procedures late after repair of tetralogy of fallot: Current perspectives and contemporary approaches to management.","volume":"33","author":"Bhagra","year":"2017","journal-title":"Can J Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCULATIONAHA.113.008396","article-title":"Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010.","volume":"130","author":"Marelli","year":"2014","journal-title":"Circulation."},{"key":"B28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1080\/14779072.2021.1940960","article-title":"The challenges of an aging tetralogy of Fallot population.","volume":"19","author":"Woo","year":"2021","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/ejcts\/ezz021","article-title":"Homografts versus stentless bioprosthetic valves in the pulmonary position: A multicentre propensity-matched comparison in patients younger than 20 years.","volume":"56","author":"Marathe","year":"2019","journal-title":"Eur J Cardio-thorac Surg."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.jcin.2017.04.025","article-title":"A systematic review of infective endocarditis in patients with bovine jugular vein valves compared with other valve types.","volume":"10","author":"Sharma","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"key":"B31","doi-asserted-by":"publisher","first-page":"441.e431","DOI":"10.1016\/j.jtcvs.2015.10.069","article-title":"Risk factors for development of endocarditis and reintervention in patients undergoing right ventricle to pulmonary artery valved conduit placement.","volume":"151","author":"Mery","year":"2016","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jtcvs.2018.03.156","article-title":"High incidence of late infective endocarditis in bovine jugular vein valved conduits.","volume":"156","author":"Beckerman","year":"2018","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B33","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cjco.2021.02.015","article-title":"Injection drug use endocarditis: An inner-city hospital experience.","volume":"3","author":"Syed","year":"2021","journal-title":"CJC Open."},{"key":"B34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0974-2069.93706","article-title":"The Contegra conduit: Late outcomes in right ventricular outflow tract reconstruction.","volume":"5","author":"Holmes","year":"2012","journal-title":"Ann Pediatr Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2459\/01.JCM.0000260208.98246.10","article-title":"Autografts, homografts, and xenografts: Overview on stentless aortic valve surgery.","volume":"8","author":"Luciani","year":"2007","journal-title":"J Cardiovasc Med (Hagerstown)."},{"key":"B36","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ijsu.2015.07.009","article-title":"Xenograft bioprosthetic heart valves: Past, present and future.","author":"Manji","year":"2015","journal-title":"Int J Surg."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00055","article-title":"Tissue engineered materials in cardiovascular surgery: The surgeon\u2019s perspective.","volume":"7","author":"Durko","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/eurheartj\/ehx074","article-title":"Next generation heart valve substitutes.","volume":"38","author":"Emmert","year":"2017","journal-title":"Eur Heart J."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.118.004748","article-title":"The ross procedure: A systematic review, meta-analysis, and microsimulation.","volume":"11","author":"Etnel","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"B40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jtcvs.2015.09.083","article-title":"Outcome after aortic valve replacement in children: A systematic review and meta-analysis.","volume":"151","author":"Etnel","year":"2016","journal-title":"J Thorac Cardiovasc Surg."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1740539","article-title":"Decellularized pulmonary xenograft matrix PplusN versus cryopreserved homograft for RVOT reconstruction during ross procedure in adults.","author":"Penov","year":"2021","journal-title":"Thorac Cardiovasc Surg."},{"key":"B42","doi-asserted-by":"publisher","first-page":"411","DOI":"10.21037\/acs-2021-rp-30","article-title":"Systematic review and meta-analysis of long-term outcomes in adults undergoing the Ross procedure.","volume":"10","author":"Flynn","year":"2021","journal-title":"Ann Cardiothorac Surg."},{"key":"B43","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/ejcts\/ezz054","article-title":"A European study on decellularized homografts for pulmonary valve replacement: Initial results from the prospective ESPOIR Trial and ESPOIR Registry data\u2020.","volume":"56","author":"Boethig","year":"2019","journal-title":"Eur J Cardiothorac Surg."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2016-000500","article-title":"Conceptual model for early health technology assessment of current and novel heart valve interventions.","volume":"3","author":"Huygens","year":"2016","journal-title":"Open Heart."},{"key":"B45","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S1070-3241(16)30460-6","article-title":"Pooling research results: Benefits and limitations of meta-analysis.","volume":"25","author":"Ioannidis","year":"1999","journal-title":"Jt Comm J Qual Improv."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis.","volume":"54","author":"Sterne","year":"2001","journal-title":"J Clin Epidemiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/01621459.1986.10478314","article-title":"The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information.","volume":"81","author":"Blackstone","year":"1986","journal-title":"J Am Stat Assoc."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1136\/heartjnl-2014-305873","article-title":"Two decades of experience with the Ross operation in neonates, infants and children from the Italian Paediatric Ross Registry.","volume":"100","author":"Luciani","year":"2014","journal-title":"Heart."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.897946\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T05:03:12Z","timestamp":1662526992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.897946\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":48,"alternative-id":["10.3389\/fcvm.2022.897946"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.897946","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"article-number":"897946"}}